Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia

American Heart Journal

Volumn 152, Issue 6, 2006, Pages 1096.e9-1096.e15

  Palazzuoli, Alberto ^a   Silverberg, Donald ^b   Iovine, Francesca ^a   Capobianco, Stefano ^a   Giannotti, Giovanna ^a   Calabrò, Anna ^a   Campagna, Stella Maria ^a   Nuti, Ranuccio ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; FERROUS GLUCONATE; HEMOGLOBIN; IRON; PLACEBO; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDURANCE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FUNCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MALE; MONOTHERAPY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33845216454     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2006.08.005     Document Type: Article

References (27)

1. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. J Am Coll Cardiol 46 (2005) 1116-1143
2. Tendera M. Epidemiology, treatment and guidelines for the treatment of heart failure in Europe. Eur Heart J (Suppl) 7 Suppl J (2005) J5-J9
3. Silverberg D.S., Wexler D., and Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?. J Nephrology 17 (2004) 749-761
4. Felker G.M., Adams Jr. K.F., Gattis W.A., et al. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44 (2004) 959-966
5. Lindenfeld J. Prevalence of anemia and effects on mortality in patients with heart failure. Am Heart J 149 (2005) 391-401
6. Silverberg D.S., Wexler D., Blum M., et al. The use of subcutaneous Erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 35 (2000) 1737-1744
7. Silverberg D.S., Wexler D., Sheps D., et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 37 (2001) 1775-1780
8. Mancini D.M., Katz S.D., Lang C., et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 107 (2003) 294-299
9. Cleland J.G., Coletta A.P., Clark A.L., et al. Clinical trial updates from the European Society of Cardiology and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA. Eur J Heart Fail 7 (2005) 937-939
10. Wu A.H.B., Omland T., Knudsen C.W., et al. Relationship of B-Type Natriuretic Peptide and anemia in patients with and without heart failure: a substudy from the breathing not normal multinational study. Am J Hematol 80 (2005) 174-180
11. Cockroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
12. Schiller N.B., Shah P.N., Crawford M., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
13. Strzelczyk T., Cusick D.A., Pfeifer P.B., et al. Value of the Bruce protocol to determine peak exercise oxygen consumption in patients evaluated for cardiac transplantation. Am Heart J 142 (2001) 466-475
14. Stelken A.M., Younis L.T., and Jennison S.H. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 27 (1996) 345-352
15. ACSM American college of sport medicine (ACSM's). Guidelines for exercise testing and prescription (2000), Lippincott Williams and Wilkins, Baltimore
16. Cink R.E., and Thomas T.R. Validity of the astrand-ryhming nomogram for predicting maximal oxygen intake. Br J Sports Med 15 (1981) 182-185
17. Jones M., Ibels L., Schenkel B., et al. Impact of epoetin alpha on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int 65 (2004) 757-767
18. Shapiro B.P., Chen H.H., Burnett J.C., et al. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc 78 (2003) 481-486
19. Kanka H., Kita Y., Okamura T., et al. What factors are associated with high B-type natriuretic peptide levels in a general Japanese population?. J Hum Hypertens 19 (2005) 165-172
20. Srivistava P.N., Thomas M.C., Calafiore P., et al. Diastolic dysfunction in patients with type 2 diabetes. Clin Sci 110 (2006) 109-116
21. Anand I.S., Chandrashekhar Y., Ferrari R., et al. Pathogenesis of edema in chronic anemia: studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br Heart J 70 (1993) 357-362
22. Van der Meer P., Voors A.A., Lipsic E., et al. Erythropoietin in cardiovascular diseases. Eur Heart J 13 (2004) 285-291
23. Van der Meer P., Lipsic E., Henning R.H., et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol 46 (2005) 125-133
24. Ingle L., Rigby A.S., Nabb S., et al. Clinical determinants of poor six-minute walk test performance in patients with left ventricular systolic dysfunction and no major structural heart disease. Eur J Heart Fail 8 (2006) 321-325
25. Maiese K., Li F., and Chong Z.Z. New avenues of exploration for erythropoietin. JAMA 293 (2005) 90-95
26. Gouva C., Nikolopoulos P., Ioannidis J.P.A., et al. Treating anemia early in renal failure slows the decline of renal function: a randomized controlled study. Kidney Int 66 (2004) 753-760
27. Khan N.A., Ma I., Thompson C.R., et al. Kidney function and mortality among patients with left ventricular systolic dysfunction. J Am Soc Nephrol 17 (2006) 244-253